BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 7523897)

  • 1. The parallelogram approach in studies of genotoxic effects.
    Anderson D; Sorsa M; Waters MD
    Mutat Res; 1994; 313(2-3):101-15. PubMed ID: 7523897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidelines for the evaluation of chemicals for carcinogenicity. Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment.
    Rep Health Soc Subj (Lond); 1991; 42():1-80. PubMed ID: 1763238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mode of action-based risk assessment of genotoxic carcinogens.
    Hartwig A; Arand M; Epe B; Guth S; Jahnke G; Lampen A; Martus HJ; Monien B; Rietjens IMCM; Schmitz-Spanke S; Schriever-Schwemmer G; Steinberg P; Eisenbrand G
    Arch Toxicol; 2020 Jun; 94(6):1787-1877. PubMed ID: 32542409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic alterations induced by genotoxic occupational and environmental human chemical carcinogens: A systematic literature review.
    Chappell G; Pogribny IP; Guyton KZ; Rusyn I
    Mutat Res Rev Mutat Res; 2016; 768():27-45. PubMed ID: 27234561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of genotoxic chemicals among animal and human carcinogens evaluated in the IARC Monograph Series.
    Bartsch H; Malaveille C
    Cell Biol Toxicol; 1989 Jun; 5(2):115-27. PubMed ID: 2766027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prospects for a simplified and internationally harmonized approach to the detection of possible human carcinogens and mutagens.
    Ashby J
    Mutagenesis; 1986 Jan; 1(1):3-16. PubMed ID: 3325732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel, integrated in vitro carcinogenicity test to identify genotoxic and non-genotoxic carcinogens using human lymphoblastoid cells.
    Wilde EC; Chapman KE; Stannard LM; Seager AL; Brüsehafer K; Shah UK; Tonkin JA; Brown MR; Verma JR; Doherty AT; Johnson GE; Doak SH; Jenkins GJS
    Arch Toxicol; 2018 Feb; 92(2):935-951. PubMed ID: 29110037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical structure, Salmonella mutagenicity and extent of carcinogenicity as indicators of genotoxic carcinogenesis among 222 chemicals tested in rodents by the U.S. NCI/NTP.
    Ashby J; Tennant RW
    Mutat Res; 1988 Jan; 204(1):17-115. PubMed ID: 3277047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classification according to chemical structure, mutagenicity to Salmonella and level of carcinogenicity of a further 42 chemicals tested for carcinogenicity by the U.S. National Toxicology Program.
    Ashby J; Tennant RW; Zeiger E; Stasiewicz S
    Mutat Res; 1989 Jun; 223(2):73-103. PubMed ID: 2662004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A structural analysis of the genotoxic and carcinogenic potentials of cyclosporin A.
    Rosenkranz HS; Klopman G
    Mutagenesis; 1992 Mar; 7(2):115-8. PubMed ID: 1579066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term tests, genotoxicity and carcinogenicity in light of a multivariate statistical exploration.
    Benigni R
    Ann Ist Super Sanita; 1989; 25(4):573-5. PubMed ID: 2631623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omeprazole: an exploration of its reported genotoxicity.
    Rosenkranz HS; Klopman G
    Mutagenesis; 1991 Sep; 6(5):381-4. PubMed ID: 1795642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The relation between carcinogenesis and mutagenesis: a re-evaluation].
    Bartsch H; Malaveille C
    Bull Acad Natl Med; 1989 Nov; 173(8):1005-12; discussion 1013-5. PubMed ID: 2633853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro testing for carcinogens and mutagens.
    Santella RM
    Occup Med; 1987; 2(1):39-46. PubMed ID: 3306977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagenicity-carcinogenicity as related to teratogenic activity.
    Alia M; Laborda E; Antón FA
    Bull Environ Contam Toxicol; 1992 Feb; 48(2):275-81. PubMed ID: 1531619
    [No Abstract]   [Full Text] [Related]  

  • 16. Deployment of short-term assays for the detection of carcinogens; genetic and molecular considerations.
    Ramel C
    Mutat Res; 1986 Nov; 168(3):327-42. PubMed ID: 3540645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophilicity of nongenotoxic carcinogens and genotoxic noncarcinogens as measured by the ke test.
    Bakale G; McCreary RD
    Prog Clin Biol Res; 1990; 340D():355-65. PubMed ID: 2371305
    [No Abstract]   [Full Text] [Related]  

  • 18. Prediction of cancer potency using a battery of mutation and toxicity data.
    Travis CC; Saulsbury AW; Pack SA
    Mutagenesis; 1990 May; 5(3):213-9. PubMed ID: 2385175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validity of considering that early changes may act as indicators for non-genotoxic carcinogenesis.
    Hildebrand B; Grasso P; Ashby J; Chamberlain M; Jung R; van Kolfschoten A; Loeser E; Smith E; Bontinck WJ
    Mutat Res; 1991 Jun; 248(2):217-20. PubMed ID: 2046680
    [No Abstract]   [Full Text] [Related]  

  • 20. Non-genotoxic factors in the carcinogenetic process: problems of detection and hazard evaluation.
    Parodi S; Malacarne D; Taningher M
    Toxicol Lett; 1992 Dec; 64-65 Spec No():621-30. PubMed ID: 1471216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.